Actively Recruiting
Coagulopathy of Immunodermatologic Diseases
Led by University of Nebraska · Updated on 2026-05-12
39
Participants Needed
1
Research Sites
186 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will examine the coagulation and fibrinolysis profiles of those with autoimmune skin diseases. Blood samples will be collected from participants with active/poorly controlled immune-mediated skin diseases and mild/latent/well-controlled immune-mediated skin diseases. A one-time sample from 15 general dermatology outpatients who do not have a known or suspected diagnosis of bullous diseases, immune-mediated dermatologic condition, or cutaneous malignancy will also be collected to serve as control. Blood samples from both participant populations will be analyzed for coagulation and inflammatory markers and compared. The results of this study may help inform future studies on the utility of analyzing coagulation and fibrinolysis profiles of patients with autoimmune skin diseases.
CONDITIONS
Official Title
Coagulopathy of Immunodermatologic Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of immune-mediated skin disease such as bullous pemphigoid, pemphigus vulgaris, mucous membrane pemphigoid, cutaneous lupus erythematosus, or dermatomyositis for the study group
- No diagnosis of immune-mediated skin disease for the control group
- Receiving care from one or more of the Principal or Secondary Investigators for the study group
- Age 19 years or older
You will not qualify if you...
- Unable or unfit to provide consent
- Use of P2Y12 inhibitors in the past 4 weeks
- History of internal malignancy before enrollment or suspected internal/systemic malignancy during the study (excluding pre-malignant or early-stage local cutaneous malignancies)
- Major surgery or trauma (e.g., accident causing bone fracture) within 4 weeks of the study
- Other autoimmune diseases not in remission with a flare in the last 12 weeks
- Inability to provide detailed medical history or insufficient history on record
- Younger than 19 years old
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Nebraska Medical Center
Omaha, Nebraska, United States, 68198
Actively Recruiting
Research Team
M
Megan E Wackel, MS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here